1. Inicio
  2. Proyectos y Estudios
  3. A Phase 3, Open-Label Study to Investigate the Long-Term Safety and Efficacy of LP352 in the Treatment of Seizures in Children and Adults with Developmental and Epileptic Encephalopathy.

A Phase 3, Open-Label Study to Investigate the Long-Term Safety and Efficacy of LP352 in the Treatment of Seizures in Children and Adults with Developmental and Epileptic Encephalopathy.

Datos básicos

ENSAYO CLÍNICO LP352-303 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2025

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

LONGBOARD PHARMACEUTICALS INC

Compartir